EYENOVIA TO REPORT FOURTH QUARTER AND FULL YEAR 2020 RESULTS ON THURSDAY, MARCH 25

Print Friendly, PDF & Email

NEW YORK, March 18, 2021 (GLOBE NEWSWIRE) — Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic company developing a pipeline of advanced therapeutics based on its proprietary microdose array print (MAP™) platform technology, today announced that the Company will release financial results for the fourth quarter and full year ended December 31, 2020 on Thursday, March 25, 2021, after market close. Following the release, Eyenovia’s Chief Executive Officer and Chief Medical Officer, Dr. Sean Ianchulev, Chief Operating Officer, Michael Rowe, and Chief Financial Officer, John Gandolfo, will host a conference call to review the financial and operating results.

 

Click here to read more.